Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (331-340 of 359) with videos related to

Pageof 36
Sort By:
Human Mutation|November 1, 2012
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeatsJulie van der Zee, Ilse Gijselinck, Lubina Dillen, et al.
Acta Neuropathologica|May 22, 2010
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degenerationHazel Urwin, Keith A Josephs, Jonathan D Rohrer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Journal of Alzheimer'S Disease : JAD|August 25, 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease PathologyLiu Shi, Laura M Winchester, Benjamine Y Liu, et al.
Archives of Neurology|April 13, 2011
Genetic and clinical features of progranulin-associated frontotemporal lobar degenerationAlice S Chen-Plotkin, Maria Martinez-Lage, Patrick M A Sleiman, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 36

Showing results (331-340 of 359) with videos related to

Sort By:
Pageof 36
Human Mutation|November 1, 2012
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeatsJulie van der Zee, Ilse Gijselinck, Lubina Dillen, et al.
Acta Neuropathologica|May 22, 2010
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degenerationHazel Urwin, Keith A Josephs, Jonathan D Rohrer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood-based multivariate methylation risk score for cognitive impairment and dementiaJarno Koetsier, Rachel Cavill, Rick Reijnders, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 8, 2021
Characteristics of subjective cognitive decline associated with amyloid positivityOlin Janssen, Willemijn J Jansen, Stephanie J B Vos, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryPiotr Lewczuk, Peter Riederer, Sid E O'Bryant, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Journal of Alzheimer'S Disease : JAD|August 25, 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease PathologyLiu Shi, Laura M Winchester, Benjamine Y Liu, et al.
Archives of Neurology|April 13, 2011
Genetic and clinical features of progranulin-associated frontotemporal lobar degenerationAlice S Chen-Plotkin, Maria Martinez-Lage, Patrick M A Sleiman, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 36